These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9926716)

  • 1. [Oral antidiabetic drugs].
    Tauber JP
    Rev Prat; 1999 Jan; 49(1):46-50. PubMed ID: 9926716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
    Harrigan RA; Nathan MS; Beattie P
    Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic management of the patient with type 2 diabetes.
    Quinn L
    Nurs Clin North Am; 2001 Jun; 36(2):217-42, vi. PubMed ID: 11382561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapy of type 2 diabetes. Critical evaluation of oral antidiabetic drugs].
    Landgraf R
    MMW Fortschr Med; 2000 May; 142(21):33-7. PubMed ID: 10872292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy with oral antidiabetic drugs].
    Kautzky-Willer A; Lechleitner M; Pieber TR; Prager R; Roden M; Wascher TC; Weitgasser R
    Acta Med Austriaca; 2004; 31(5):162-3. PubMed ID: 15747987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents for the treatment of type 2 diabetes mellitus.
    Campbell RK
    Ann Pharmacother; 2007 Jan; 41(1):51-60. PubMed ID: 17190843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antidiabetic agents and renal insufficiency].
    Robles NR; Blanco J
    Nefrologia; 2002; 22(4):325-8. PubMed ID: 12369123
    [No Abstract]   [Full Text] [Related]  

  • 11. [Oral antidiabetic drugs in 2003].
    Ducobu J
    Rev Med Brux; 2003 Sep; 24(4):A361-8. PubMed ID: 14606302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology and treatment of patients with type 2 diabetes exhibiting failure to oral drugs.
    Efendic S; Alvarsson M; Brismar K; Wagner H
    Acta Physiol (Oxf); 2008 Jan; 192(1):117-25. PubMed ID: 18171434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
    Yki-Järvinen H
    Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes.
    Arulmozhi DK; Kurian R; Bodhankar SL; Veeranjaneyulu A
    J Pharm Pharmacol; 2008 Sep; 60(9):1167-73. PubMed ID: 18718120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.
    Snyder RW; Berns JS
    Semin Dial; 2004; 17(5):365-70. PubMed ID: 15461745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational choice of oral antihyperglycaemic agents.
    Chowdhury S; Sengupta N
    J Indian Med Assoc; 2002 Mar; 100(3):174-5, 177. PubMed ID: 12408278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of insulin treatment on insulin sensitivity in insulin requiring type 2 diabetes patients.
    Mayorov AY; Naumenkova IV; Antsiferov MB; Dedov II
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S54-9. PubMed ID: 15955377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modern approaches to pharmacotherapy of diabetes mellitus type II].
    Kovel'man IR; Tochilkin AI; Beliaeva NF; Gorodetskiĭ VK; Kniazhev VA; Tkachenko SB; Semenov LL; Semenova NV
    Vopr Med Khim; 2002; 48(4):337-52. PubMed ID: 12506608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polypharmacy with oral antidiabetic agents: an indicator of poor glycemic control.
    Willey CJ; Andrade SE; Cohen J; Fuller JC; Gurwitz JH
    Am J Manag Care; 2006 Aug; 12(8):435-40. PubMed ID: 16886886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensifying insulin therapy in patients with type 2 diabetes mellitus.
    Hirsch IB
    Am J Med; 2005 May; 118 Suppl 5A():21S-6S. PubMed ID: 15850550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.